#USA #Atlanta #CAST Surgical #LevaLap #JSLS

Groundbreaking Acceptance of CAST Surgical's Clinical Trial

Core Access Surgical Technologies, Inc. (CAST) has achieved a significant milestone by having its latest clinical trial manuscript accepted for publication in the esteemed Journal of the Society of Laparoscopic and Robotic Surgeons (JSLS). This journal is well-recognized for its focus on minimally invasive surgery and offers an open-access platform for innovative research. The study primarily highlights the efficacy of the LevaLap™ 1.0 device, which has been steadily gaining traction across surgical theaters worldwide.

The research confirms not only the clinical effectiveness of LevaLap™ 1.0 but also its value, propelling interest and adoption among the next generation of surgeons. According to Dr. Ricardo Azziz, the corresponding author of this study, the results clearly show that even seasoned surgeons can benefit from the ease and control that LevaLap™ 1.0 offers during laparoscopic procedures involving the Veress needle. As the demand for minimally invasive techniques increases, this device promises enhanced safety and speed, regardless of a surgeon's experience level.

Acknowledgment of Contributions

CAST extends its heartfelt gratitude to JSLS for providing an authoritative platform for this pivotal research. The journal plays a vital role in advancing the field of minimally invasive surgery by facilitating the sharing of scientific knowledge and innovation. Being included in this global dialogue underlines CAST's commitment to improving surgical outcomes through rigorous research and collaboration.

"We are thrilled to celebrate this key advancement towards standardizing the Veress Needle access technique in laparoscopic surgery with the LevaLap™ 1.0 device," remarked Thomas A. Gordy, Chairman and CEO of CAST. This study, a multicenter initiative involving surgeons from various backgrounds, underscores the versatility, safety, and efficacy of the LevaLap™ device, making it easier for medical professionals to adopt. The clinical implications of this research mark a transition towards enhanced surgical outcomes and broader acceptance of laparoscopic access techniques around the globe.

About CAST Surgical

Based in the United States, CAST is a pioneering global medical device company dedicated to designing, developing, and manufacturing laparoscopic surgical access tools. The company's mission is to deliver superior and innovative solutions that provide unique value both clinically and economically to the medical community. Further information about CAST and its products can be accessed at www.castsurgical.com.

About JSLS

The Journal of the Society of Laparoscopic and Robotic Surgeons (JSLS) stands out as a premier peer-reviewed publication dedicated to promoting minimally invasive surgery practices. Its consistent ranking within the top 1% of over 16,000 journals on PubMed Central showcases its high level of readership and engagement among the medical community.

This acceptance not only marks a crucial point in CAST's journey but also showcases the transformative power of innovative surgical technology in contemporary medicine.